BnR Summit 2026

Belt & Road Summit - Deal-Making 2026

9 – 15 Sept 2026 | Hong Kong, China (Hong Kong)

Ab&B Biotech

en.abbbio.com/China
15 profile visits

About

Ab&B Biotech Co.,Ltd. is committed to the full-cycle development of innovative human vaccines from research and development through registration, industrial production to commercialization while adhering to international standards and maintaining our focus on independent innovation. Our Shanghai and Taizhou R&D Centers with pilot-scale platforms are actively developing multiple vaccine pipelines including viral vaccines, bacterial vaccines, conjugate vaccines, recombinant subunit vaccines and mRNA vaccines.

Areas of activity

Manufacturing

Manufacturing

Technology

Bio-Tech

Additional information

Other Place of Business

Hong KongMainland China

Terms and Conditions & Disclaimer

I agree

Representatives

BD Director

Ab&B Biotech

Marketplace (1)

  • Project

    License Out of Monkey Pox mRNA Vaccine

    We have a FDA & NMPA IND Approval Monkey Pox mRNA Vaccine ready for License Out.

    • Yes
    • Yes
    • Technology
    • Manufacturing
    • Private Project
    • Equity (private)
    • Financial Services
    • Idea / Concept Stage
    • Open for negotiation
    • Open for Negotiation
    • 50,000,001 USD or above
    • 25,000,001 to 50,000,000 USD
    Author

    BD Director at Ab&B Biotech

    China